Goldman Sachs’s ProShares Ultra Health Care RXL Stock Holding History

Goldman Sachs’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-21,008	Closed	-$316K	–	6970
2016 Q4	$316K	Sell	21,008 -1,940	-8%	-$29.4K	﹤0.01%	5447
2016 Q3	$378K	Buy	22,948 +5,920	+35%	+$99.9K	﹤0.01%	5296
2016 Q2	$272K	Buy	+17,028	New	+$263K	﹤0.01%	5430
2015 Q4	–	Sell	-58,284	Closed	-$830K	–	7315
2015 Q3	$830K	Sell	58,284 -53,732	-48%	-$957K	﹤0.01%	4658
2015 Q2	$2.08M	Buy	+112,016	New	+$2.04M	﹤0.01%	3791
2014 Q4	–	Sell	-20,520	Closed	-$276K	–	7286
2014 Q3	$276K	Sell	20,520 -168	-0.8%	-$2.17K	﹤0.01%	5836
2014 Q2	$254K	Sell	20,688 -6,008	-23%	-$68.2K	﹤0.01%	6010
2014 Q1	$301K	Buy	+26,696	New	+$295K	﹤0.01%	5732

Other funds holding RXL

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BRC

Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

RPG

Risk Paradigm Group Austin, Texas $117M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs's RXL Position: Q1 2017 in Review

Goldman Sachs sold out of ProShares Ultra Health Care (RXL) in Q1 2017, closing a stake of 21,008 shares — an estimated $316K sold.

Goldman Sachs first reported a position in RXL in Q1 2014 and held it in 8 quarters. The position peaked at $2.08M in Q2 2015. 16 funds tracked by Wall St. Rank hold RXL as of Q1 2017.

Goldman Sachs reported no remaining ProShares Ultra Health Care position as of Q1 2017 after selling out during the quarter.
Goldman Sachs sold 21,008 ProShares Ultra Health Care shares in Q1 2017, an estimated $316K.
Goldman Sachs first reported a position in ProShares Ultra Health Care in Q1 2014 and held it in 8 quarters.
Goldman Sachs's ProShares Ultra Health Care position peaked at $2.08M in Q2 2015.
16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.